<?xml version="1.0" encoding="UTF-8"?>
<p>General recommendations for treatment are limited because of the lack of effective antiviral agents and powered clinical studies. Initial evaluation of patients with underlying hematological malignancies and/or undergoing HCT includes full clinical history and examination (Table 
 <xref rid="onco13306-tbl-0001" ref-type="table">1</xref>) along with chest x‚Äêray and computerized tomography (CT) scan of the chest 
 <xref rid="onco13306-bib-0060" ref-type="ref">60</xref>. Laboratory evaluation for respiratory viruses is essential to document active infection (i.e., nasopharyngeal aspirate, nasal and/or throat swabs, saline throat gargles or sputum samples by polymerase chain reaction) 
 <xref rid="onco13306-bib-0063" ref-type="ref">63</xref>, 
 <xref rid="onco13306-bib-0064" ref-type="ref">64</xref>.
</p>
